{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T16:22:43Z","timestamp":1794932563029,"version":"4.9.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T00:00:00Z","timestamp":1742947200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T00:00:00Z","timestamp":1742947200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1038\/s41401-025-01522-w","type":"journal-article","created":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T03:52:06Z","timestamp":1742961126000},"page":"2151-2162","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Huperzine A attenuates epileptic seizures via enhancing dCA1-projecting septal cholinergic transmission"],"prefix":"10.1038","volume":"46","author":[{"given":"Yu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke-yu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-yang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-jie","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Fei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ceng-lin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-jia","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu-hong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-nong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-lu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1350-2961","authenticated-orcid":false,"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4755-9357","authenticated-orcid":false,"given":"Zhong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,26]]},"reference":[{"key":"1522_CR1","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S0140-6736(18)32596-0","volume":"393","author":"RD Thijs","year":"2019","unstructured":"Thijs RD, Surges R, O\u2019Brien TJ, Sander JW. Epilepsy in adults. Lancet. 2019;393:689\u2013701.","journal-title":"Lancet"},{"key":"1522_CR2","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/s41573-024-00981-w","volume":"23","author":"P Klein","year":"2024","unstructured":"Klein P, Kaminski RM, Koepp M, L\u00f6scher W. New epilepsy therapies in development. Nat Rev Drug Discov. 2024;23:682\u2013708.","journal-title":"Nat Rev Drug Discov"},{"key":"1522_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2021.108026","volume":"233","author":"C Xu","year":"2022","unstructured":"Xu C, Gong Y, Wang Y, Chen Z. New advances in pharmacoresistant epilepsy towards precise management-from prognosis to treatments. Pharmacol Ther. 2022;233:108026.","journal-title":"Pharmacol Ther"},{"key":"1522_CR4","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1212\/WNL.0b013e318216eb7b","volume":"76","author":"MS Rafii","year":"2011","unstructured":"Rafii MS, Walsh S, Little JT, Behan K, Reynolds B, Ward C, et al. A phase II trial of huperzine A in mild to moderate Alzheimer disease. Neurology. 2011;76:1389\u201394.","journal-title":"Neurology"},{"key":"1522_CR5","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1111\/epi.14557","volume":"59","author":"M Bialer","year":"2018","unstructured":"Bialer M, Johannessen SI, Koepp MJ, Levy RH, Perucca E, Tomson T, et al. Progress report on new antiepileptic drugs: a summary of the Fourteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIV). I. Drugs in preclinical and early clinical development. Epilepsia. 2018;59:1811\u201341.","journal-title":"Epilepsia"},{"key":"1522_CR6","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/1440-1681.13064","volume":"46","author":"P Mohseni-Moghaddam","year":"2019","unstructured":"Mohseni-Moghaddam P, Sadr SS, Roghani M, Arabzadeh S, Khamse S, Zamani E, et al. Huperzine A ameliorates cognitive dysfunction and neuroinflammation in kainic acid-induced epileptic rats by antioxidant activity and NLRP3\/caspase-1 pathway inhibition. Clin Exp Pharmacol Physiol. 2019;46:360\u201372.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"1522_CR7","doi-asserted-by":"publisher","first-page":"357","DOI":"10.3389\/fphar.2016.00357","volume":"7","author":"JC Wong","year":"2016","unstructured":"Wong JC, Dutton SB, Collins SD, Schachter S, Escayg A. Huperzine A provides robust and sustained protection against induced seizures in Scn1a mutant mice. Front Pharmacol. 2016;7:357.","journal-title":"Front Pharmacol"},{"key":"1522_CR8","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1038\/s41386-021-00985-9","volume":"46","author":"JC Wong","year":"2021","unstructured":"Wong JC, Grieco SF, Dutt K, Chen L, Thelin JT, Inglis GAS, et al. Autistic-like behavior, spontaneous seizures, and increased neuronal excitability in a Scn8a mouse model. Neuropsychopharmacology. 2021;46:2011\u201320.","journal-title":"Neuropsychopharmacology"},{"key":"1522_CR9","doi-asserted-by":"publisher","first-page":"ENEURO.0068-001","DOI":"10.1523\/ENEURO.0068-15.2015","volume":"2","author":"MT Dinday","year":"2015","unstructured":"Dinday MT, Baraban SC. Large-scale phenotype-based antiepileptic drug screening in a zebrafish model of dravet syndrome. eNeuro. 2015;2:ENEURO.0068-0015.","journal-title":"eNeuro"},{"key":"1522_CR10","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.jneumeth.2008.04.019","volume":"172","author":"G Curia","year":"2008","unstructured":"Curia G, Longo D, Biagini G, Jones RS, Avoli M. The pilocarpine model of temporal lobe epilepsy. J Neurosci Methods. 2008;172:143\u201357.","journal-title":"J Neurosci Methods"},{"key":"1522_CR11","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1001\/archneurpsyc.1945.02300110075013","volume":"54","author":"FM Foster","year":"1945","unstructured":"Foster FM. Action of acetylcholine on motor cortex; correlation of effects of acetylcholine and epilepsy. Arch Neurol Psychiatry. 1945;54:391\u20134.","journal-title":"Arch Neurol Psychiatry"},{"key":"1522_CR12","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1046\/j.1460-9568.2000.00077.x","volume":"12","author":"I Ferencz","year":"2000","unstructured":"Ferencz I, Leanza G, Nanobashvili A, Kokaia M, Lindvall O. Basal forebrain neurons suppress amygdala kindling via cortical but not hippocampal cholinergic projections. Eur J Neurosci. 2000;12:2107\u201316.","journal-title":"Eur J Neurosci"},{"key":"1522_CR13","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.expneurol.2018.11.008","volume":"314","author":"JP Andrews","year":"2019","unstructured":"Andrews JP, Yue Z, Ryu JH, Neske G, McCormick DA, Blumenfeld H. Mechanisms of decreased cholinergic arousal in focal seizures: in vivo whole-cell recordings from the pedunculopontine tegmental nucleus. Exp Neurol. 2019;314:74\u201381.","journal-title":"Exp Neurol"},{"key":"1522_CR14","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.biopsych.2019.11.014","volume":"87","author":"Y Wang","year":"2020","unstructured":"Wang Y, Wang Y, Xu C, Wang S, Tan N, Chen C, et al. Direct septum-hippocampus cholinergic circuit attenuates seizure through driving somatostatin inhibition. Biol Psychiatry. 2020;87:843\u201356.","journal-title":"Biol Psychiatry"},{"key":"1522_CR15","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1111\/cns.13617","volume":"27","author":"Y Wang","year":"2021","unstructured":"Wang Y, Shen Y, Cai X, Yu J, Chen C, Tan B, et al. Deep brain stimulation in the medial septum attenuates temporal lobe epilepsy via entrainment of hippocampal theta rhythm. CNS Neurosci Ther. 2021;27:577\u201386.","journal-title":"CNS Neurosci Ther"},{"key":"1522_CR16","doi-asserted-by":"crossref","unstructured":"Zheng Y, Xu C, Sun J, Ming W, Dai S, Shao Y, et al. Excitatory somatostatin interneurons in the dentate gyrus drive a widespread seizure network in cortical dysplasia. Signal Transduct Target Ther. 2023;8:186.","DOI":"10.1038\/s41392-023-01404-9"},{"key":"1522_CR17","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1038\/s41401-023-01075-w","volume":"44","author":"Y Wang","year":"2023","unstructured":"Wang Y, Qiu XY, Liu JY, Tan B, Wang F, Sun MJ, et al. (+)-Borneol enantiomer ameliorates epileptic seizure via decreasing the excitability of glutamatergic transmission. Acta Pharmacol Sin. 2023;44:1600\u201311.","journal-title":"Acta Pharmacol Sin"},{"key":"1522_CR18","doi-asserted-by":"publisher","first-page":"3519","DOI":"10.1111\/bph.15076","volume":"177","author":"Y Tang","year":"2020","unstructured":"Tang Y, Feng B, Wang Y, Sun H, You Y, Yu J, et al. Structure-based discovery of CZL80, a caspase-1 inhibitor with therapeutic potential for febrile seizures and later enhanced epileptogenic susceptibility. Br J Pharmacol. 2020;177:3519\u201334.","journal-title":"Br J Pharmacol"},{"key":"1522_CR19","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.neuron.2017.06.004","volume":"95","author":"Y Wang","year":"2017","unstructured":"Wang Y, Xu C, Xu Z, Ji C, Liang J, Wang Y, et al. Depolarized GABAergic signaling in subicular microcircuits mediates generalized seizure in temporal lobe epilepsy. Neuron. 2017;95:92\u2013105.e105.","journal-title":"Neuron"},{"key":"1522_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32742-x","volume":"13","author":"F Fei","year":"2022","unstructured":"Fei F, Wang X, Xu C, Shi J, Gong Y, Cheng H, et al. Discrete subicular circuits control generalization of hippocampal seizures. Nat Commun. 2022;13:5010.","journal-title":"Nat Commun"},{"key":"1522_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34662-2","volume":"13","author":"J Zhao","year":"2022","unstructured":"Zhao J, Sun J, Zheng Y, Zheng Y, Shao Y, Li Y, et al. Activated astrocytes attenuate neocortical seizures in rodent models through driving Na+-K+-ATPase. Nat Commun. 2022;13:7136.","journal-title":"Nat Commun"},{"key":"1522_CR22","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.seizure.2011.01.003","volume":"20","author":"W Loscher","year":"2011","unstructured":"Loscher W. Critical review of current animal models of seizures and epilepsy used in the discovery and development of new antiepileptic drugs. Seizure. 2011;20:359\u201368.","journal-title":"Seizure"},{"key":"1522_CR23","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1007\/s11064-017-2222-z","volume":"42","author":"W Loscher","year":"2017","unstructured":"Loscher W. Animal models of seizures and epilepsy: past, present, and future role for the discovery of antiseizure drugs. Neurochem Res. 2017;42:1873\u201388.","journal-title":"Neurochem Res"},{"key":"1522_CR24","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/jnr.490240220","volume":"24","author":"XC Tang","year":"1989","unstructured":"Tang XC, De Sarno P, Sugaya K, Giacobini E. Effect of huperzine A, a new cholinesterase inhibitor, on the central cholinergic system of the rat. J Neurosci Res. 1989;24:276\u201385.","journal-title":"J Neurosci Res"},{"key":"1522_CR25","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.neuron.2016.09.021","volume":"92","author":"DG Tervo","year":"2016","unstructured":"Tervo DG, Hwang BY, Viswanathan S, Gaj T, Lavzin M, Ritola KD, et al. A designer AAV variant permits efficient retrograde access to projection neurons. Neuron. 2016;92:372\u201382.","journal-title":"Neuron"},{"key":"1522_CR26","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1038\/s41592-020-0953-2","volume":"17","author":"M Jing","year":"2020","unstructured":"Jing M, Li Y, Zeng J, Huang P, Skirzewski M, Kljakic O, et al. An optimized acetylcholine sensor for monitoring in vivo cholinergic activity. Nat Methods. 2020;17:1139\u201346.","journal-title":"Nat Methods"},{"key":"1522_CR27","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.cell.2013.04.017","volume":"153","author":"C Yang","year":"2013","unstructured":"Yang C, Chiang M, Gray D, Prabhakaran M, Alvarado M, Juntti S, et al. Sexually dimorphic neurons in the ventromedial hypothalamus govern mating in both sexes and aggression in males. Cell. 2013;153:896\u2013909.","journal-title":"Cell"},{"key":"1522_CR28","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.cell.2022.12.033","volume":"186","author":"Z Fan","year":"2023","unstructured":"Fan Z, Chang J, Liang Y, Zhu H, Zhang C, Zheng D, et al. Neural mechanism underlying depressive-like state associated with social status loss. Cell. 2023;186:560\u2013576 e517.","journal-title":"Cell"},{"key":"1522_CR29","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.tins.2021.11.006","volume":"45","author":"AC Letsinger","year":"2022","unstructured":"Letsinger AC, Gu Z, Yakel JL. \u03b17 nicotinic acetylcholine receptors in the hippocampal circuit: taming complexity. Trends Neurosci. 2022;45:145\u201357.","journal-title":"Trends Neurosci"},{"key":"1522_CR30","doi-asserted-by":"crossref","unstructured":"Becchetti A, Grandi LC, Cerina M, Amadeo A. Nicotinic acetylcholine receptors and epilepsy. Pharmacol Res. 2023;189:106698.","DOI":"10.1016\/j.phrs.2023.106698"},{"key":"1522_CR31","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/BF02229077","volume":"16","author":"HS White","year":"1995","unstructured":"White HS, Johnson M, Wolf HH, Kupferberg HJ. The early identification of anticonvulsant activity: role of the maximal electroshock and subcutaneous pentylenetetrazol seizure models. Ital J Neuro Sci. 1995;16:73\u201377.","journal-title":"Ital J Neuro Sci"},{"key":"1522_CR32","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.eplepsyres.2015.08.012","volume":"117","author":"R Gersner","year":"2015","unstructured":"Gersner R, Ekstein D, Dhamne SC, Schachter SC, Rotenberg A. Huperzine A prophylaxis against pentylenetetrazole-induced seizures in rats is associated with increased cortical inhibition. Epilepsy Res. 2015;117:97\u2013103.","journal-title":"Epilepsy Res"},{"issue":"Suppl. 8","key":"1522_CR33","first-page":"220","volume":"46","author":"HS White","year":"2005","unstructured":"White HS, Schachter S, Lee D, Xiaoshen J, Eisenberg D. Anticonvulsant activity of Huperzine A, an alkaloid extractof Chinese club moss (Huperzia serrata). Epilepsia. 2005;46(Suppl. 8):220.","journal-title":"Epilepsia"},{"key":"1522_CR34","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.eplepsyres.2015.01.001","volume":"111","author":"M Bialer","year":"2015","unstructured":"Bialer M, Johannessen SI, Levy RH, Perucca E, Tomson T, White HS. Progress report on new antiepileptic drugs: a summary of the Twelfth Eilat Conference (EILAT XII). Epilepsy Res. 2015;111:85\u2013141.","journal-title":"Epilepsy Res"},{"key":"1522_CR35","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1002\/jat.805","volume":"21","author":"RK Gordon","year":"2001","unstructured":"Gordon RK, Nigam SV, Weitz JA, Dave JR, Doctor BP, Ved HS. The NMDA receptor ion channel: a site for binding of huperzine A. J Appl Toxicol. 2001;21:S47\u2013S51.","journal-title":"J Appl Toxicol"},{"key":"1522_CR36","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/0014-2999(91)90730-E","volume":"203","author":"M McKinney","year":"1991","unstructured":"McKinney M, Miller JH, Yamada F, Tuckmantel W, Kozikowski AP. Potencies and stereoselectivities of enantiomers of huperzine A for inhibition of rat cortical acetylcholinesterase. Eur J Pharmacol. 1991;203:303\u20135.","journal-title":"Eur J Pharmacol"},{"key":"1522_CR37","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1111\/j.1460-9568.2008.06070.x","volume":"27","author":"G Zimmerman","year":"2008","unstructured":"Zimmerman G, Njunting M, Ivens S, Tolner EA, Behrens CJ, Gross M, et al. Acetylcholine-induced seizure-like activity and modified cholinergic gene expression in chronically epileptic rats. Eur J Neurosci. 2008;27:965\u201375.","journal-title":"Eur J Neurosci"},{"key":"1522_CR38","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/j.1527-3458.1999.tb00105.x","volume":"5","author":"XC Tang","year":"1999","unstructured":"Tang XC, Han YF. Pharmacological profile of Huperzine A, a novel acetylcholinesterase inhibitor from chinese herb. CNS Drug Rev. 1999;5:281\u2013300.","journal-title":"CNS Drug Rev"},{"key":"1522_CR39","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1177\/1535759720949240","volume":"20","author":"PA Forcelli","year":"2020","unstructured":"Forcelli PA. Septal signaling suppresses seizures through stimulating somatostatin cells. Epilepsy Curr. 2020;20:297\u20139.","journal-title":"Epilepsy Curr"},{"key":"1522_CR40","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1523\/JNEUROSCI.13-02-00596.1993","volume":"13","author":"P S\u00e9gu\u00e9la","year":"1993","unstructured":"S\u00e9gu\u00e9la P, Wadiche J, Dineley-Miller K, Dani JA, Patrick JW. Molecular cloning, functional properties, and distribution of rat brain alpha 7: a nicotinic cation channel highly permeable to calcium. J Neurosci. 1993;13:596\u2013604.","journal-title":"J Neurosci"},{"key":"1522_CR41","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1152\/jn.00316.2001","volume":"87","author":"AV Buhler","year":"2002","unstructured":"Buhler AV, Dunwiddie TV. alpha7 nicotinic acetylcholine receptors on GABAergic interneurons evoke dendritic and somatic inhibition of hippocampal neurons. J Neurophysiol. 2002;87:548\u201357.","journal-title":"J Neurophysiol"},{"key":"1522_CR42","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.brainres.2006.10.001","volume":"1130","author":"K Kawa","year":"2007","unstructured":"Kawa K. Inhibitory synaptic transmission in area postrema neurons of the rat showing robust presynaptic facilitation mediated by nicotinic ACh receptors. Brain Res. 2007;1130:83\u201394.","journal-title":"Brain Res"},{"key":"1522_CR43","doi-asserted-by":"publisher","first-page":"12538","DOI":"10.1073\/pnas.1408805111","volume":"111","author":"M Ishibashi","year":"2014","unstructured":"Ishibashi M, Yamazaki Y, Miledi R, Sumikawa K. Nicotinic and muscarinic agonists and acetylcholinesterase inhibitors stimulate a common pathway to enhance GluN2B-NMDAR responses. Proc Natl Acad Sci USA. 2014;111:12538\u201343.","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01522-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01522-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01522-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T10:02:07Z","timestamp":1757152927000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01522-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,26]]},"references-count":43,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["1522"],"URL":"https:\/\/doi.org\/10.1038\/s41401-025-01522-w","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,26]]},"assertion":[{"value":"6 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}